All Pharma News
Ultragenyx Completes FDA End-Of-Phase 2 Meeting For GTX-102

Ultragenyx Completes FDA End-Of-Phase 2 Meeting For GTX-102
GLOBENEWSWIRE
17 Jul 2024
Share Share
Ultragenyx eyes accelerated US filing for Sanfilippo gene therapy

Ultragenyx eyes accelerated US filing for Sanfilippo gene therapy
Nick Paul Taylor FIERCE BIOTECH
14 Jun 2024
Share Share
Ultragenyx Prices Public Offering Of Common Stock, Pre-Funded Warrants

Ultragenyx Prices Public Offering Of Common Stock, Pre-Funded Warrants
GLOBENEWSWIRE
13 Jun 2024
Share Share
Ultragenyx, Mereo`s brittle bone drug sustains fracture rate cut

Ultragenyx, Mereo`s brittle bone drug sustains fracture rate cut
Nick Paul Taylor FIERCE BIOTECH
13 Jun 2024
Share Share
Ultragenyx & Mereo BioPharma Announce New Pha2 Data from Phase 2/3 Orbit Study

Ultragenyx & Mereo BioPharma Announce New Pha2 Data from Phase 2/3 Orbit Study
GLOBENEWSWIRE
11 Jun 2024
Share Share
Ultragenyx: Participating At Goldman Sachs Healthcare Conference

Ultragenyx: Participating At Goldman Sachs Healthcare Conference
GLOBENEWSWIRE
04 Jun 2024
Share Share
Ultragenyx Positive Phase 3 Results For DTX401 In Glycogen Storage Disease

Ultragenyx Positive Phase 3 Results For DTX401 In Glycogen Storage Disease
GLOBENEWSWIRE
30 May 2024
Share Share
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
17 May 2024
Share Share
Ultragenyx to Participate at Bank of America`s 2024 Healthcare Conference

Ultragenyx to Participate at Bank of America`s 2024 Healthcare Conference
GLOBENEWSWIRE
06 May 2024
Share Share
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update

Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GLOBENEWSWIRE
02 May 2024
Share Share